共 117 条
[1]
Dougados M(1996)Recommendations for the registration of drugs used in the treatment of osteoarthritis Ann Rheum Dis 55 552-557
[2]
Devogelaer JP(1998)Chondroitin sulfate and joint disease Osteoarthritis Cartilage 6 3-5
[3]
Annefeldt M(1992)Proteoglycans: many forms, many functions FASEB J 6 861-870
[4]
Hardingham TE(1991)Proteoglycans of articular cartilage: changes in aging and in joint disease Semin Arthritis Rheum 20 12-33
[5]
Hardingham TE(1998)Effects of chondroitin sulfate and interleukin-1b on human articular chondrocytes cultivated in clusters Osteoarthritis Cartilage 6 196-204
[6]
Fosang AJ(1998)Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit Osteoarthritis Cartilage 6 6-13
[7]
Hardingham TE(1998)Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg versus placebo Osteoarthritis Cartilage 6 25-30
[8]
Bayliss MT(1996)Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis J Rheumatol 23 8-8
[9]
Bassleer CT(1998)Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis Osteoarthritis Cartilage 6 31-36
[10]
Comban JPA(1991)Antireactive properties of glucosamine sulfate Arzneimittelforschung 41 157-161